Mass Spectrometric/Bioinformatic Identification of a Protein Subset That Characterizes the Cellular Activity of Anticancer Peptides
- 29 September 2014
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 13 (11) , 5250-5261
Abstract
The preclinical study of the mechanism of action of anticancer small molecules is challenging due to the complexity of cancer biology and the fragmentary nature of available data. With the aim of identifying a protein subset characterizing the cellular activity of anticancer peptides, we used differential mass spectrometry to identify proteomic changes induced by two peptides, LR and [d-Gln4]LR, that inhibit cell growth and compared them with the changes induced by a known drug, pemetrexed, targeting the same enzyme, thymidylate synthase. The quantification of the proteome of an ovarian cancer cell model treated with LR yielded a differentially expressed protein data set with respect to untreated cells. This core set was expanded by bioinformatic data interpretation, the biologically relevant proteins were selected, and their differential expression was validated on three cis-platinum sensitive and resistant ovarian cancer cell lines. Via clustering of the protein network features, a broader view of the peptides’ cellular activity was obtained. Differences from the mechanism of action of pemetrexed were inferred from different modulation of the selected proteins. The protein subset identification represents a method of general applicability to characterize the cellular activity of preclinical compounds and a tool for monitoring the cellular activity of novel drug candidates.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (IG10474)
This publication has 45 references indexed in Scilit:
- A cross-platform toolkit for mass spectrometry and proteomicsNature Biotechnology, 2012
- Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinomaMolecular Systems Biology, 2012
- TRAP-1, the mitochondrial Hsp90Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthaseProceedings of the National Academy of Sciences, 2011
- Reactome: a database of reactions, pathways and biological processesNucleic Acids Research, 2010
- Proteomic Analysis of Nuclei Isolated from Cancer Cell Lines Treated with Indenoisoquinoline NSC 724998, a Novel Topoisomerase I InhibitorJournal of Proteome Research, 2010
- IDEAL-Q, an Automated Tool for Label-free Quantitation Analysis Using an Efficient Peptide Alignment Approach and Spectral Data ValidationMolecular & Cellular Proteomics, 2010
- Targeting HSP90 for cancer therapyBritish Journal of Cancer, 2009
- Large‐scale mapping of human protein–protein interactions by mass spectrometryMolecular Systems Biology, 2007
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970